CEFEPIME

Generic: CEFEPIME HYDROCHLORIDE, CEFEPIME

Sagent PharmaceuticalsManufacturer
INTRAMUSCULAR, INTRAVENOUSRoute
CEFEPIME HYDROCHLORIDEActive Substance
2008-03-20Original Approval

CEFEPIME is FDA application ANDA065441, sponsored by ACS DOBFAR. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
DRUG INEFFECTIVE
1,605 reports
2
ACUTE KIDNEY INJURY
1,289 reports
3
OFF LABEL USE
1,233 reports
4
PYREXIA
1,110 reports
5
FEBRILE NEUTROPENIA
887 reports
6
PNEUMONIA
826 reports
7
SEPSIS
619 reports
8
HYPOTENSION
601 reports
9
ENCEPHALOPATHY
568 reports
10
NEUTROPENIA
558 reports